androstane-3,17-diol has been researched along with Cushing's Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deslypere, JP; Punjabi, U; Sayed, A; Verdonck, L; Vermeulen, A | 1 |
| Ito, T; Iwata, J; Nakagawa, K; Sakuta, H; Suzuki, T | 1 |
2 other study(ies) available for androstane-3,17-diol and Cushing's Syndrome
| Article | Year |
|---|---|
Plasma 5 alpha-androstane-3 alpha,17 beta-diol and urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide, parameters of peripheral androgen action: a comparative study.
Topics: Adolescent; Adrenalectomy; Adult; Aged; Aging; Androgens; Androstane-3,17-diol; Androstanols; Cosyntropin; Cushing Syndrome; Female; Glucuronates; Hirsutism; Humans; Male; Menopause; Middle Aged | 1982 |
[Unidentified steroid hormone of Cushing's syndrome and disease].
Topics: 17-Ketosteroids; Adenoma; Adenoma, Basophil; Adrenal Gland Neoplasms; Adult; Androstane-3,17-diol; Chromatography, High Pressure Liquid; Cushing Syndrome; Female; Hormones; Humans; Male; Middle Aged; Pituitary Neoplasms | 1993 |